Notice on Convening 2023 Annual General Meeting
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Notice on Convening 2023 Annual General Meeting
Filed with SSE ·
6ix hasn’t read this filing yet.
Mayinglong Pharmaceutical Group Co., Ltd. on 6ix
Earlier from Mayinglong Pharmaceutical
- Announcement on Attending Online Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction in 2024
- Announcement on Resolutions of 12th Session of 11th Board of Directors
- Announcement on Resolutions of 11th Session of 11th Board of Directors
- Announcement on Release of Pledge and Re-Pledge of Some Shares by Controlling Shareholder
- 3rd Quarter Report of 2023
Later from Mayinglong Pharmaceutical
- Announcement on Changing Name of Shareholder
- Announcement on Convening Performance Meeting for 2023 and 1st Quarter of 2024
- Announcement on Resolutions of 2023 Annual General Meeting
- Announcement on Implementation of Dividend Distribution for 2023
- Announcement on Extending the Duration of Industrial Investment Fund
Follow Mayinglong Pharmaceutical into a list and get an email when it puts out news.
Follow Mayinglong Pharmaceutical